Implementation Strategies to Increase PrEP Uptake in the South

Purpose of Review Seven years after TDF/FTC was approved for pre-exposure prophylaxis to reduce risks of HIV infection, there have been large increases in the number of persons using PrEP in the USA. However, recent data on pre-exposure prophylaxis (PrEP) use at the state level indicate that people...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Current HIV/AIDS reports 2019-08, Vol.16 (4), p.259-269
Hauptverfasser: Sullivan, Patrick S., Mena, Leandro, Elopre, Latesha, Siegler, Aaron J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 269
container_issue 4
container_start_page 259
container_title Current HIV/AIDS reports
container_volume 16
creator Sullivan, Patrick S.
Mena, Leandro
Elopre, Latesha
Siegler, Aaron J.
description Purpose of Review Seven years after TDF/FTC was approved for pre-exposure prophylaxis to reduce risks of HIV infection, there have been large increases in the number of persons using PrEP in the USA. However, recent data on pre-exposure prophylaxis (PrEP) use at the state level indicate that people living in the Southern United States are underserved by PrEP relative to their epidemic need. We sought to review possible reasons for inequitable uptake of PrEP in the South and identify implementation approaches to increase PrEP uptake in the South. Recent Findings Published literature, data on the locations of PrEP service providers, recent data on PrEP utilization from pharmacy prescription databases, HIV surveillance data and government data on healthcare providers, and health literacy indicate a confluence of factors in the South that are likely limiting PrEP uptake. A variety of approaches are needed to address the complex challenges to PrEP implementation in the South. These include considering alternative PrEP provision strategies (e.g., pharmacy-based PrEP, telemedicine-delivered PrEP), conducting gain-based stigma-reduction campaigns, increasing capacity for reimbursement for PrEP medications and services through policy change to expand Medicaid and to preserve access to Affordable Care Act–compliant health plans, expanding STI screening programs and improving integration of PrEP offering with delivery of positive STI results, using mHealth tools to screen groups at highest risk for HIV (e.g., men who have sex with men) periodically to increase correct perception of risk, and streamlining clinical procedures to allow same-day PrEP starts for patients without obvious medical contraindications. Summary Overcoming the structural, capacity, and policy challenges to increasing PrEP uptake in the South will require innovations in clinical approaches, leveraging technologies, and policy changes. The South has unique challenges to achieving equitable PrEP uptake, and addressing key barriers to expanded PrEP use will require multisectoral responses.
doi_str_mv 10.1007/s11904-019-00447-4
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7117066</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2255457893</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-12dc84695b94ff2eff5ff9c9f0b99c5bb394f07d7d32ec02e91b03140180b62c3</originalsourceid><addsrcrecordid>eNp9kU9P3DAQxa0KVCj0C_SAInHpJWX8J3F8QaoQ0JWQWGnhbDne8W5oEm9tB6nfHsPSbemB01gzv3mep0fIFwrfKIA8i5QqECVQVQIIIUvxgRzSSjQlr2S9t3vXzQH5FOMDABdK1B_JAadUSl7zQ3I-GzY9Djgmkzo_FosUTMJVh7FIvpiNNqCJWMzD5by43yTzE4tuLNIai4Wf0vqY7DvTR_z8Wo_I_dXl3cWP8ub2enbx_aa0QopUUra0jahV1SrhHEPnKueUVQ5apWzVtjz3QS7lkjO0wFDRFjgVQBtoa2b5ETnf6m6mdsClzfcG0-tN6AYTfmtvOv12MnZrvfKPWmanUNdZ4OurQPC_JoxJD1202PdmRD9FzVhViUo2imf09D_0wU9hzPaeqYZBdiIzxbaUDT7GgG53DAX9HI_exqNzPPolHi3y0sm_NnYrf_LIAN8CMY_GFYa_f78j-wT-gJqY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2258208467</pqid></control><display><type>article</type><title>Implementation Strategies to Increase PrEP Uptake in the South</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Sullivan, Patrick S. ; Mena, Leandro ; Elopre, Latesha ; Siegler, Aaron J.</creator><creatorcontrib>Sullivan, Patrick S. ; Mena, Leandro ; Elopre, Latesha ; Siegler, Aaron J.</creatorcontrib><description>Purpose of Review Seven years after TDF/FTC was approved for pre-exposure prophylaxis to reduce risks of HIV infection, there have been large increases in the number of persons using PrEP in the USA. However, recent data on pre-exposure prophylaxis (PrEP) use at the state level indicate that people living in the Southern United States are underserved by PrEP relative to their epidemic need. We sought to review possible reasons for inequitable uptake of PrEP in the South and identify implementation approaches to increase PrEP uptake in the South. Recent Findings Published literature, data on the locations of PrEP service providers, recent data on PrEP utilization from pharmacy prescription databases, HIV surveillance data and government data on healthcare providers, and health literacy indicate a confluence of factors in the South that are likely limiting PrEP uptake. A variety of approaches are needed to address the complex challenges to PrEP implementation in the South. These include considering alternative PrEP provision strategies (e.g., pharmacy-based PrEP, telemedicine-delivered PrEP), conducting gain-based stigma-reduction campaigns, increasing capacity for reimbursement for PrEP medications and services through policy change to expand Medicaid and to preserve access to Affordable Care Act–compliant health plans, expanding STI screening programs and improving integration of PrEP offering with delivery of positive STI results, using mHealth tools to screen groups at highest risk for HIV (e.g., men who have sex with men) periodically to increase correct perception of risk, and streamlining clinical procedures to allow same-day PrEP starts for patients without obvious medical contraindications. Summary Overcoming the structural, capacity, and policy challenges to increasing PrEP uptake in the South will require innovations in clinical approaches, leveraging technologies, and policy changes. The South has unique challenges to achieving equitable PrEP uptake, and addressing key barriers to expanded PrEP use will require multisectoral responses.</description><identifier>ISSN: 1548-3568</identifier><identifier>ISSN: 1548-3576</identifier><identifier>EISSN: 1548-3576</identifier><identifier>DOI: 10.1007/s11904-019-00447-4</identifier><identifier>PMID: 31177363</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Anti-HIV Agents - therapeutic use ; Emtricitabine - therapeutic use ; Epidemics ; HIV ; HIV Infections - drug therapy ; HIV Infections - prevention &amp; control ; Homosexuality, Male ; Human immunodeficiency virus ; Humans ; Implementation Science (E Geng ; Male ; Mass Screening ; Medication Adherence - psychology ; Medicine ; Medicine &amp; Public Health ; Patient Protection and Affordable Care Act ; Pharmacy ; Pre-Exposure Prophylaxis - methods ; Prophylaxis ; Safe Sex - psychology ; Section Editor ; Sexual and Gender Minorities ; Social Stigma ; Telemedicine ; Tenofovir - therapeutic use ; Topical Collection on Implementation Science ; United States</subject><ispartof>Current HIV/AIDS reports, 2019-08, Vol.16 (4), p.259-269</ispartof><rights>Springer Science+Business Media, LLC, part of Springer Nature 2019</rights><rights>Copyright Springer Nature B.V. 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-12dc84695b94ff2eff5ff9c9f0b99c5bb394f07d7d32ec02e91b03140180b62c3</citedby><cites>FETCH-LOGICAL-c474t-12dc84695b94ff2eff5ff9c9f0b99c5bb394f07d7d32ec02e91b03140180b62c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11904-019-00447-4$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11904-019-00447-4$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,314,776,780,881,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31177363$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sullivan, Patrick S.</creatorcontrib><creatorcontrib>Mena, Leandro</creatorcontrib><creatorcontrib>Elopre, Latesha</creatorcontrib><creatorcontrib>Siegler, Aaron J.</creatorcontrib><title>Implementation Strategies to Increase PrEP Uptake in the South</title><title>Current HIV/AIDS reports</title><addtitle>Curr HIV/AIDS Rep</addtitle><addtitle>Curr HIV/AIDS Rep</addtitle><description>Purpose of Review Seven years after TDF/FTC was approved for pre-exposure prophylaxis to reduce risks of HIV infection, there have been large increases in the number of persons using PrEP in the USA. However, recent data on pre-exposure prophylaxis (PrEP) use at the state level indicate that people living in the Southern United States are underserved by PrEP relative to their epidemic need. We sought to review possible reasons for inequitable uptake of PrEP in the South and identify implementation approaches to increase PrEP uptake in the South. Recent Findings Published literature, data on the locations of PrEP service providers, recent data on PrEP utilization from pharmacy prescription databases, HIV surveillance data and government data on healthcare providers, and health literacy indicate a confluence of factors in the South that are likely limiting PrEP uptake. A variety of approaches are needed to address the complex challenges to PrEP implementation in the South. These include considering alternative PrEP provision strategies (e.g., pharmacy-based PrEP, telemedicine-delivered PrEP), conducting gain-based stigma-reduction campaigns, increasing capacity for reimbursement for PrEP medications and services through policy change to expand Medicaid and to preserve access to Affordable Care Act–compliant health plans, expanding STI screening programs and improving integration of PrEP offering with delivery of positive STI results, using mHealth tools to screen groups at highest risk for HIV (e.g., men who have sex with men) periodically to increase correct perception of risk, and streamlining clinical procedures to allow same-day PrEP starts for patients without obvious medical contraindications. Summary Overcoming the structural, capacity, and policy challenges to increasing PrEP uptake in the South will require innovations in clinical approaches, leveraging technologies, and policy changes. The South has unique challenges to achieving equitable PrEP uptake, and addressing key barriers to expanded PrEP use will require multisectoral responses.</description><subject>Anti-HIV Agents - therapeutic use</subject><subject>Emtricitabine - therapeutic use</subject><subject>Epidemics</subject><subject>HIV</subject><subject>HIV Infections - drug therapy</subject><subject>HIV Infections - prevention &amp; control</subject><subject>Homosexuality, Male</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Implementation Science (E Geng</subject><subject>Male</subject><subject>Mass Screening</subject><subject>Medication Adherence - psychology</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Patient Protection and Affordable Care Act</subject><subject>Pharmacy</subject><subject>Pre-Exposure Prophylaxis - methods</subject><subject>Prophylaxis</subject><subject>Safe Sex - psychology</subject><subject>Section Editor</subject><subject>Sexual and Gender Minorities</subject><subject>Social Stigma</subject><subject>Telemedicine</subject><subject>Tenofovir - therapeutic use</subject><subject>Topical Collection on Implementation Science</subject><subject>United States</subject><issn>1548-3568</issn><issn>1548-3576</issn><issn>1548-3576</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU9P3DAQxa0KVCj0C_SAInHpJWX8J3F8QaoQ0JWQWGnhbDne8W5oEm9tB6nfHsPSbemB01gzv3mep0fIFwrfKIA8i5QqECVQVQIIIUvxgRzSSjQlr2S9t3vXzQH5FOMDABdK1B_JAadUSl7zQ3I-GzY9Djgmkzo_FosUTMJVh7FIvpiNNqCJWMzD5by43yTzE4tuLNIai4Wf0vqY7DvTR_z8Wo_I_dXl3cWP8ub2enbx_aa0QopUUra0jahV1SrhHEPnKueUVQ5apWzVtjz3QS7lkjO0wFDRFjgVQBtoa2b5ETnf6m6mdsClzfcG0-tN6AYTfmtvOv12MnZrvfKPWmanUNdZ4OurQPC_JoxJD1202PdmRD9FzVhViUo2imf09D_0wU9hzPaeqYZBdiIzxbaUDT7GgG53DAX9HI_exqNzPPolHi3y0sm_NnYrf_LIAN8CMY_GFYa_f78j-wT-gJqY</recordid><startdate>20190801</startdate><enddate>20190801</enddate><creator>Sullivan, Patrick S.</creator><creator>Mena, Leandro</creator><creator>Elopre, Latesha</creator><creator>Siegler, Aaron J.</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20190801</creationdate><title>Implementation Strategies to Increase PrEP Uptake in the South</title><author>Sullivan, Patrick S. ; Mena, Leandro ; Elopre, Latesha ; Siegler, Aaron J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-12dc84695b94ff2eff5ff9c9f0b99c5bb394f07d7d32ec02e91b03140180b62c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Anti-HIV Agents - therapeutic use</topic><topic>Emtricitabine - therapeutic use</topic><topic>Epidemics</topic><topic>HIV</topic><topic>HIV Infections - drug therapy</topic><topic>HIV Infections - prevention &amp; control</topic><topic>Homosexuality, Male</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Implementation Science (E Geng</topic><topic>Male</topic><topic>Mass Screening</topic><topic>Medication Adherence - psychology</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Patient Protection and Affordable Care Act</topic><topic>Pharmacy</topic><topic>Pre-Exposure Prophylaxis - methods</topic><topic>Prophylaxis</topic><topic>Safe Sex - psychology</topic><topic>Section Editor</topic><topic>Sexual and Gender Minorities</topic><topic>Social Stigma</topic><topic>Telemedicine</topic><topic>Tenofovir - therapeutic use</topic><topic>Topical Collection on Implementation Science</topic><topic>United States</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sullivan, Patrick S.</creatorcontrib><creatorcontrib>Mena, Leandro</creatorcontrib><creatorcontrib>Elopre, Latesha</creatorcontrib><creatorcontrib>Siegler, Aaron J.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Current HIV/AIDS reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sullivan, Patrick S.</au><au>Mena, Leandro</au><au>Elopre, Latesha</au><au>Siegler, Aaron J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Implementation Strategies to Increase PrEP Uptake in the South</atitle><jtitle>Current HIV/AIDS reports</jtitle><stitle>Curr HIV/AIDS Rep</stitle><addtitle>Curr HIV/AIDS Rep</addtitle><date>2019-08-01</date><risdate>2019</risdate><volume>16</volume><issue>4</issue><spage>259</spage><epage>269</epage><pages>259-269</pages><issn>1548-3568</issn><issn>1548-3576</issn><eissn>1548-3576</eissn><abstract>Purpose of Review Seven years after TDF/FTC was approved for pre-exposure prophylaxis to reduce risks of HIV infection, there have been large increases in the number of persons using PrEP in the USA. However, recent data on pre-exposure prophylaxis (PrEP) use at the state level indicate that people living in the Southern United States are underserved by PrEP relative to their epidemic need. We sought to review possible reasons for inequitable uptake of PrEP in the South and identify implementation approaches to increase PrEP uptake in the South. Recent Findings Published literature, data on the locations of PrEP service providers, recent data on PrEP utilization from pharmacy prescription databases, HIV surveillance data and government data on healthcare providers, and health literacy indicate a confluence of factors in the South that are likely limiting PrEP uptake. A variety of approaches are needed to address the complex challenges to PrEP implementation in the South. These include considering alternative PrEP provision strategies (e.g., pharmacy-based PrEP, telemedicine-delivered PrEP), conducting gain-based stigma-reduction campaigns, increasing capacity for reimbursement for PrEP medications and services through policy change to expand Medicaid and to preserve access to Affordable Care Act–compliant health plans, expanding STI screening programs and improving integration of PrEP offering with delivery of positive STI results, using mHealth tools to screen groups at highest risk for HIV (e.g., men who have sex with men) periodically to increase correct perception of risk, and streamlining clinical procedures to allow same-day PrEP starts for patients without obvious medical contraindications. Summary Overcoming the structural, capacity, and policy challenges to increasing PrEP uptake in the South will require innovations in clinical approaches, leveraging technologies, and policy changes. The South has unique challenges to achieving equitable PrEP uptake, and addressing key barriers to expanded PrEP use will require multisectoral responses.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>31177363</pmid><doi>10.1007/s11904-019-00447-4</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1548-3568
ispartof Current HIV/AIDS reports, 2019-08, Vol.16 (4), p.259-269
issn 1548-3568
1548-3576
1548-3576
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7117066
source MEDLINE; SpringerLink Journals
subjects Anti-HIV Agents - therapeutic use
Emtricitabine - therapeutic use
Epidemics
HIV
HIV Infections - drug therapy
HIV Infections - prevention & control
Homosexuality, Male
Human immunodeficiency virus
Humans
Implementation Science (E Geng
Male
Mass Screening
Medication Adherence - psychology
Medicine
Medicine & Public Health
Patient Protection and Affordable Care Act
Pharmacy
Pre-Exposure Prophylaxis - methods
Prophylaxis
Safe Sex - psychology
Section Editor
Sexual and Gender Minorities
Social Stigma
Telemedicine
Tenofovir - therapeutic use
Topical Collection on Implementation Science
United States
title Implementation Strategies to Increase PrEP Uptake in the South
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T13%3A54%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Implementation%20Strategies%20to%20Increase%20PrEP%20Uptake%20in%20the%20South&rft.jtitle=Current%20HIV/AIDS%20reports&rft.au=Sullivan,%20Patrick%20S.&rft.date=2019-08-01&rft.volume=16&rft.issue=4&rft.spage=259&rft.epage=269&rft.pages=259-269&rft.issn=1548-3568&rft.eissn=1548-3576&rft_id=info:doi/10.1007/s11904-019-00447-4&rft_dat=%3Cproquest_pubme%3E2255457893%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2258208467&rft_id=info:pmid/31177363&rfr_iscdi=true